Kelli Musa is the practitioner women find after everyone else has failed them. A functional medicine clinician with two decades of clinical practice, Harvard nutrition credentials, and SSRP certification, Kelli is the founder of Peptides First and the architect of The Metabolic Code, a clinical framework rebuilding how women are evaluated, treated, and tracked through midlife. Her thesis is clinical and inconvenient. Metabolism is the driver. Weight, mood, energy, and hormones are downstream of it. Most women aren’t broken. They’ve been read in fragments by a system that runs five tests in twelve minutes and calls it care. She knows the cost of that system personally. Her mother, Carrie, died at forty-three after being dismissed for years. That story is not a grief narrative. It is the clinical case that built the practice. Today, Kelli has helped thousands of women navigate perimenopause, post-pill recovery, and metabolic adaptation, and her practice does not compete with med spas. It replaces them. She speaks nationally on peptide therapeutics, female longevity, and metabolic medicine, and is currently writing her first book, Ms. Managed.
Kelli Musa
Continue exploring related topics.
VIEW ALLDr. Seeds’ Office Hours – Episode 095
1. Sjögren’s, POTS, Mold, Biofilms & Lumbrokinase (0:45)
2. PMDD, Allopregnanolone & Mitochondrial Efficiency (7:28)
3. Retatrutide, Glucagon & Metabolic Flexibility (20:01)
Cellular Optimization for EDS Surgical Support
Dr. Seeds reviews peptide and supplemental considerations for cellular optimization in an EDS patient preparing for orthopedic surgery. (Question Link)
The Phosphatidylcholine Pathway
Dr. Seeds expands on Journal Club Episode 92 to explore the role of phosphatidylcholine in lipid metabolism, methylation, and mitochondrial integrity during aging. He also highlights how estrogen loss may impact this pathway, especially in pre- and post-menopausal women.
Aging-Associated Decline of Phosphatidylcholine Synthesis is a Malleable Trigger of Natural Mitochondrial Aging
Dr. Seeds explores how age-related decline in phosphatidylcholine synthesis may contribute to mitochondrial aging and why that matters in Cellular Medicine. This discussion connects membrane integrity, mitochondrial function, methylation, and metabolic resilience, while highlighting how this pathway may be more modifiable than we once thought.
1. Managing shingles outbreaks in GLP-1 patient through peptides (0:40)
2. Peptide strategies in suspected ALS (15:56)
3. Improving durability in dementia treatment (25:08)